ESC 365 - Novel treatment options in Heart Failure management: Implications for daily clinical practice enhancement.

Open Access

Novel treatment options in Heart Failure management: Implications for daily clinical practice enhancement.

Session: What did change in Heart Failure patient management since the last EHRA?

Topic: Device Therapy

Speaker: Professor J. Steffel (Zurich, CH)

Sponsored by ABBOTT

Event: EHRA 2021

Congress Session

About the speaker

Professor Jan Steffel

Hirslanden Heart Center, Zurich (Switzerland)

57 presentations

6 followers

8 more presentations in this session

Introduction.

Speaker: Professor J. Steffel (Zurich, CH)

How innovation can help in optimizing your CRT in 2021.

Speaker: Doctor N. Rivas (Barcelona, ES)

Live Q&A.

Changing the course of heart failure – impact of transcatheter mitral & tricuspid repair therapies.

Speaker: Professor C. Butter (Bernau bei Berlin, DE)

Live Q&A.

Access the full session

What did change in Heart Failure patient management since the last EHRA?

Speakers: Professor J. Steffel, Professor J. Steffel, Doctor N. Rivas, Professor C. Butter

About the event

EHRA 2021

23 April - 25 April 2021

Sessions Presentations

Congress

Related content

ESC Premium Access

New foundational therapy in heart failure with reduced ejection fraction: should we keep following the 2016 European Society of Cardiology Heart Failure Guideline in 2021?

28 August 2021

ESC Premium Access

Acute cardiac manifestations of SARS-CoV-2 infection: spotting the clot.

27 August 2021

This platform is supported by